Papers associated with gabarap

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 10 11 12 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

referenced by:

	Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions., Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, Chebib M, McGregor IS, Arnold JC., Epilepsia. November 1, 2019; 60 (11): 2224-2234.
	Natural product incarvillateine aggravates epileptic seizures by inhibiting GABAA currents., Bian X, Zhang Y, Huang B, Wang X, Wang G, Zhu Y, Liu Y, Liang J, Jia Y, Wang K., Eur J Pharmacol. September 5, 2019; 858 172496.
	Steady-State Activation and Modulation of the Concatemeric α1β2γ2L GABAA Receptor., Germann AL, Pierce SR, Burbridge AB, Steinbach JH, Akk G., Mol Pharmacol. September 1, 2019; 96 (3): 320-329.
	Steady-state activation and modulation of the synaptic-type α1β2γ2L GABAA receptor by combinations of physiological and clinical ligands., Germann AL, Pierce SR, Senneff TC, Burbridge AB, Steinbach JH, Akk G., Physiol Rep. September 1, 2019; 7 (18): e14230.
	A FLIPR Assay for Discovery of GABAA Receptor Modulators of Natural Origin., Faleschini MT, Maier A, Fankhauser S, Thasis K, Hebeisen S, Hamburger M, Butterweck V., Planta Med. August 1, 2019; 85 (11-12): 925-933.
	Involvement of the GABAA receptor α subunit in the mode of action of etifoxine., Mattei C, Taly A, Soualah Z, Saulais O, Henrion D, Guérineau NC, Verleye M, Legros C., Pharmacol Res. July 1, 2019; 145 104250.
	Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors., Mansikkamäki S, Sinkkonen ST, Korpi ER, Lüddens H., Eur J Pharmacol. June 15, 2019; 853 247-255.
	Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model., Sun LL, Yang TY, Wei NN, Lu W, Jiao WX, Zhou QQ, Miao YZ, Gao Q, Wang XT, Sun Q, Wang K., Acta Pharmacol Sin. June 1, 2019; 40 (6): 737-745.
	Functional genomics of epilepsy-associated mutations in the GABAA receptor subunits reveal that one mutation impairs function and two are catastrophic., Absalom NL, Ahring PK, Liao VW, Balle T, Jiang T, Anderson LL, Arnold JC, McGregor IS, Bowen MT, Chebib M., J Biol Chem. April 12, 2019; 294 (15): 6157-6171.
	Ketone body modulation of ligand-gated ion channels., Pflanz NC, Daszkowski AW, James KA, Mihic SJ., Neuropharmacology. April 1, 2019; 148 21-30.
	Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites., Szabo A, Nourmahnad A, Halpin E, Forman SA., Mol Pharmacol. April 1, 2019; 95 (4): 408-417.
	Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold., Guerrini G, Vergelli C, Cantini N, Giovannoni MP, Daniele S, Mascia MP, Martini C, Crocetti L., Int J Mol Sci. March 21, 2019; 20 (6):
	Interaction of insecticides with heteromeric GABA-gated chloride channels from zebrafish Danio rerio (Hamilton)., Huang QT, Sheng CW, Jiang J, Tang T, Jia ZQ, Han ZJ, Zhao CQ., J Hazard Mater. March 15, 2019; 366 643-650.
	Multiple functional neurosteroid binding sites on GABAA receptors., Chen ZW, Bracamontes JR, Budelier MM, Germann AL, Shin DJ, Kathiresan K, Qian MX, Manion B, Cheng WWL, Reichert DE, Akk G, Covey DF, Evers AS., PLoS Biol. March 7, 2019; 17 (3): e3000157.
	Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice., Li Y, Sun L, Yang T, Jiao W, Tang J, Huang X, Huang Z, Meng Y, Luo L, Wang X, Bian X, Zhang F, Wang K, Sun Q., J Med Chem. January 10, 2019; 62 (1): 159-173.
	Curare alkaloids from Matis Dart Poison: Comparison with d-tubocurarine in interactions with nicotinic, 5-HT3 serotonin and GABAA receptors., Spirova EN, Ivanov IA, Kasheverov IE, Kudryavtsev DS, Shelukhina IV, Garifulina AI, Son LV, Lummis SCR, Malca-Garcia GR, Bussmann RW, Hennig L, Giannis A, Tsetlin VI., PLoS One. January 1, 2019; 14 (1): e0210182.
	Visualizing pregnenolone sulfate-like modulators of NMDA receptor function reveals intracellular and plasma-membrane localization., Chisari M, Wilding TJ, Brunwasser S, Krishnan K, Qian M, Benz A, Huettner JE, Zorumski CF, Covey DF, Mennerick S., Neuropharmacology. January 1, 2019; 144 91-103.
	In vitro and in vivo GABAA Receptor Interaction of the Propanidid Metabolite 4-(2-[Diethylamino]-2-Oxoethoxy)-3-Methoxy-Benzeneacetic Acid., Cenani A, Brosnan RJ, Knych HK., Pharmacology. January 1, 2019; 103 (1-2): 10-16.
	Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites., Shin DJ, Germann AL, Covey DF, Steinbach JH, Akk G., Mol Pharmacol. January 1, 2019; 95 (1): 70-81.
	Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABAA receptors., Söderhielm PC, Balle T, Bak-Nyhus S, Zhang M, Hansen KM, Ahring PK, Jensen AA., Biochem Pharmacol. December 1, 2018; 158 339-358.
	A novel GABAergic dysfunction in human Dravet syndrome., Ruffolo G, Cifelli P, Roseti C, Thom M, van Vliet EA, Limatola C, Aronica E, Palma E., Epilepsia. November 1, 2018; 59 (11): 2106-2117.
	Etomidate and Etomidate Analog Binding and Positive Modulation of γ-Aminobutyric Acid Type A Receptors: Evidence for a State-dependent Cutoff Effect., McGrath M, Yu Z, Jayakar SS, Ma C, Tolia M, Zhou X, Miller KW, Cohen JB, Raines DE., Anesthesiology. November 1, 2018; 129 (5): 959-969.
	Suramin is a novel competitive antagonist selective to α1β2γ2 GABAA over ρ1 GABAC receptors., Luo H, Wood K, Shi FD, Gao F, Chang Y., Neuropharmacology. October 1, 2018; 141 148-157.
	Structural basis of neurosteroid anesthetic action on GABAA receptors., Chen Q, Wells MM, Arjunan P, Tillman TS, Cohen AE, Xu Y, Xu Y, Tang P., Nat Commun. September 28, 2018; 9 (1): 3972.
	Anesthetic-sensitive ion channel modulation is associated with a molar water solubility cut-off., Brosnan RJ, Pham TL., BMC Pharmacol Toxicol. September 14, 2018; 19 (1): 57.
	The roles of aromatic residues in the glycine receptor transmembrane domain., Tang B, Lummis SCR., BMC Neurosci. September 6, 2018; 19 (1): 53.
	Engineered Flumazenil Recognition Site Provides Mechanistic Insight Governing Benzodiazepine Modulation in GABAA Receptors., Siebert DCB, Bampali K, Puthenkalam R, Varagic Z, Sarto-Jackson I, Scholze P, Sieghart W, Mihovilovic MD, Schnürch M, Ernst M., ACS Chem Biol. August 17, 2018; 13 (8): 2040-2047.
	Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission., Knoflach F, Hernandez MC, Bertrand D., J Vis Exp. August 16, 2018; (138):
	Differential modulation of human GABAC-ρ1 receptor by sulfur-containing compounds structurally related to taurine., Ochoa-de la Paz LD, González-Andrade M, Pasantes-Morales H, Franco R, Zamora-Alvarado R, Zenteno E, Quiroz-Mercado H, Gonzales-Salinas R, Gulias-Cañizo R., BMC Neurosci. August 3, 2018; 19 (1): 47.
	Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study., May P, Girard S, Harrer M, Bobbili DR, Schubert J, Wolking S, Becker F, Lachance-Touchette P, Meloche C, Gravel M, Niturad CE, Knaus J, De Kovel C, Toliat M, Polvi A, Iacomino M, Guerrero-López R, Baulac S, Marini C, Thiele H, Altmüller J, Jabbari K, Ruppert AK, Jurkowski W, Lal D, Rusconi R, Cestèle S, Terragni B, Coombs ID, Reid CA, Striano P, Caglayan H, Siren A, Everett K, Møller RS, Hjalgrim H, Muhle H, Helbig I, Kunz WS, Weber YG, Weckhuysen S, Jonghe P, Sisodiya SM, Nabbout R, Franceschetti S, Coppola A, Vari MS, Kasteleijn-Nolst Trenité D, Baykan B, Ozbek U, Bebek N, Klein KM, Rosenow F, Nguyen DK, Dubeau F, Carmant L, Lortie A, Desbiens R, Clément JF, Cieuta-Walti C, Sills GJ, Auce P, Francis B, Johnson MR, Marson AG, Berghuis B, Sander JW, Avbersek A, McCormack M, Cavalleri GL, Delanty N, Depondt C, Krenn M, Zimprich F, Peter S, Nikanorova M, Kraaij R, van Rooij J, Balling R, Ikram MA, Uitterlinden AG, Avanzini G, Schorge S, Petrou S, Mantegazza M, Sander T, LeGuern E, Serratosa JM, Koeleman BPC, Palotie A, Lehesjoki AE, Nothnagel M, Nürnberg P, Maljevic S, Zara F, Cossette P, Krause R, Lerche H, Epicure Consortium, EuroEPINOMICS CoGIE Consortium, EpiPGX Consortium., Lancet Neurol. August 1, 2018; 17 (8): 699-708.
	Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors., Woll KA, Zhou X, Bhanu NV, Garcia BA, Covarrubias M, Miller KW, Eckenhoff RG., FASEB J. August 1, 2018; 32 (8): 4172-4189.
	Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam., Cao LQ, Montana MC, Germann AL, Shin DJ, Chakrabarti S, Mennerick S, Yuede CM, Wozniak DF, Evers AS, Akk G., Sci Rep. July 9, 2018; 8 (1): 10341.
	A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy., Ruffolo G, Di Bonaventura C, Cifelli P, Roseti C, Fattouch J, Morano A, Limatola C, Aronica E, Palma E, Giallonardo AT., Neurobiol Dis. July 1, 2018; 115 59-68.
	NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity., Papke RL, Peng C, Kumar A, Stokes C., Neurosci Lett. June 11, 2018; 677 6-13.
	Cerebellar α6 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders., Chiou LC, Lee HJ, Ernst M, Huang WJ, Chou JF, Chen HL, Mouri A, Chen LC, Treven M, Mamiya T, Fan PC, Knutson DE, Witzigmann C, Cook J, Sieghart W, Nabeshima T., Br J Pharmacol. June 1, 2018; 175 (12): 2414-2427.
	An intersubunit electrostatic interaction in the GABAA receptor facilitates its responses to benzodiazepines., Pflanz NC, Daszkowski AW, Cornelison GL, Trudell JR, Mihic SJ., J Biol Chem. May 25, 2018; 293 (21): 8264-8274.
	Direct neurotransmitter activation of voltage-gated potassium channels., Manville RW, Papanikolaou M, Abbott GW., Nat Commun. May 10, 2018; 9 (1): 1847.
	Direct intertectal inputs are an integral component of the bilateral sensorimotor circuit for behavior in Xenopus tadpoles., Gambrill AC, Faulkner RL, Cline HT., J Neurophysiol. May 1, 2018; 119 (5): 1947-1961.
	Aluminum-Activated Malate Transporters Can Facilitate GABA Transport., Ramesh SA, Kamran M, Sullivan W, Chirkova L, Okamoto M, Degryse F, McLaughlin M, Gilliham M, Tyerman SD., Plant Cell. May 1, 2018; 30 (5): 1147-1164.
	High Constitutive Activity Accounts for the Combination of Enhanced Direct Activation and Reduced Potentiation in Mutated GABAA Receptors., Germann AL, Shin DJ, Kuhrau CR, Johnson AD, Evers AS, Akk G., Mol Pharmacol. May 1, 2018; 93 (5): 468-476.
	Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels., Fourati Z, Howard RJ, Heusser SA, Hu H, Ruza RR, Sauguet L, Lindahl E, Delarue M., Cell Rep. April 24, 2018; 23 (4): 993-1004.
	Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice., Xu NZ, Ernst M, Treven M, Cerne R, Wakulchik M, Li X, Jones TM, Gleason SD, Morrow D, Schkeryantz JM, Rahman MT, Li G, Poe MM, Cook JM, Witkin JM., Psychopharmacology (Berl). April 1, 2018; 235 (4): 1151-1161.
	Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABAA receptors., Olander ER, Madjroh N, Bunch L, Söderhielm PC, Jensen AA., Biochem Pharmacol. April 1, 2018; 150 305-319.
	Towards functional selectivity for α6β3γ2 GABAA receptors: a series of novel pyrazoloquinolinones., Treven M, Siebert DCB, Holzinger R, Bampali K, Fabjan J, Varagic Z, Wimmer L, Steudle F, Scholze P, Schnürch M, Mihovilovic MD, Ernst M., Br J Pharmacol. February 1, 2018; 175 (3): 419-428.
	GABA Type A Receptor Activation in the Allosteric Coagonist Model Framework: Relationship between EC50 and Basal Activity., Akk G, Shin DJ, Germann AL, Steinbach JH., Mol Pharmacol. February 1, 2018; 93 (2): 90-100.
	Alphaxalone Binds in Inner Transmembrane β+-α- Interfaces of α1β3γ2 γ-Aminobutyric Acid Type A Receptors., Ziemba AM, Szabo A, Pierce DW, Haburcak M, Stern AT, Nourmahnad A, Halpin ES, Forman SA., Anesthesiology. February 1, 2018; 128 (2): 338-351.
	Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model., Newcombe J, Chatzidaki A, Sheppard TD, Topf M, Millar NS., Mol Pharmacol. February 1, 2018; 93 (2): 128-140.
	Propofol Is an Allosteric Agonist with Multiple Binding Sites on Concatemeric Ternary GABAA Receptors., Shin DJ, Germann AL, Johnson AD, Forman SA, Steinbach JH, Akk G., Mol Pharmacol. February 1, 2018; 93 (2): 178-189.
	Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant., Shelukhina IV, Zhmak MN, Lobanov AV, Ivanov IA, Garifulina AI, Kravchenko IN, Rasskazova EA, Salmova MA, Tukhovskaya EA, Rykov VA, Slashcheva GA, Egorova NS, Muzyka IS, Tsetlin VI, Utkin YN., Toxins (Basel). January 7, 2018; 10 (1):
	Negative modulation of the GABAA ρ1 receptor function by l-cysteine., Beltrán González AN, Vicentini F, Calvo DJ., J Neurochem. January 1, 2018; 144 (1): 50-57.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 10 11 12 ???pagination.result.next???